Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9241 - 9248 of 11616 results
A Clean Slate? California Bill Is Latest Attempt to Legislate Labeling Requirements for Cleaning Products
March 11, 2015| Blog| Viewpoint
What to Make of a Diminished Thing: Tobacco Bond Defaults and Restructurings
March 11, 2015| Advisory| Viewpoint
U.S. Advanced Energy Market Surpasses Airline Industry, Rivals Pharmaceuticals
March 11, 2015| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on March 9, 2015
March 11, 2015| Blog| Viewpoint
GAO Report Highlights Improper Medicare/Medicaid Payments
March 11, 2015| Blog| Viewpoint
Mobile Passport Control Expansion
March 10, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.